Cargando…

Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer

The Fanconi gene family has a role in DNA repair and inactivation of FANCF has been proposed as a mechanism of sensitisation to platinum chemotherapy. This study sought to confirm this hypothesis in cell lines and a large series of ovarian cancer samples. Promoter methylation was assessed by methyla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, S L, Smith, P, Syed, N, Coens, C, Wong, H, van der Burg, M, Szlosarek, P, Crook, T, Green, J A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361708/ https://www.ncbi.nlm.nih.gov/pubmed/18414472 http://dx.doi.org/10.1038/sj.bjc.6604325

Ejemplares similares

Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer
por: Cheng, Y Y, et al.
Publicado: (2008)

METH-2 silencing and promoter hypermethylation in NSCLC
por: Dunn, J R, et al.
Publicado: (2004)

– (-) Menthol Induces Reversal of Promoter Hypermethylation and Associated Up-Regulation of the FANCF Gene in the SiHa Cell Line
por: Parashar, Gaurav, et al.
Publicado: (2017)

Promoter hypermethylation of MGMT, CDH1, RAR-β and SYK tumour suppressor genes in granulosa cell tumours (GCTs) of ovarian origin
por: Dhillon, V S, et al.
Publicado: (2004)

Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia
por: Honda, T, et al.
Publicado: (2004)

Hypermethylation of genes in testicular embryonal carcinomas
por: Cheung, Hoi-Hung, et al.
Publicado: (2016)

Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia
por: Scardocci, A, et al.
Publicado: (2006)

DNA hypermethylation in the normal colonic mucosa of patients with colorectal cancer
por: Kawakami, K, et al.
Publicado: (2006)

Putative tumour suppressor gene necdin is hypermethylated and mutated in human cancer
por: De Faveri, L E, et al.
Publicado: (2013)

Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma
por: Gao, S, et al.
Publicado: (2004)

Epigenetic deregulation of multiple S100 gene family members by differential hypomethylation and hypermethylation events in medulloblastoma
por: Lindsey, J C, et al.
Publicado: (2007)

RASSF1A hypermethylation in pretreatment serum DNA of neuroblastoma patients: a prognostic marker
por: Misawa, A, et al.
Publicado: (2009)

RASSF2, a potential tumour suppressor, is silenced by CpG island hypermethylation in gastric cancer
por: Endoh, M, et al.
Publicado: (2005)

The BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: Antoniou, A C, et al.
Publicado: (2004)

Frequent downregulation of 14-3-3 σ protein and hypermethylation of 14-3-3 σ gene in salivary gland adenoid cystic carcinoma
por: Uchida, D, et al.
Publicado: (2004)

The prolyl 3-hydroxylases P3H2 and P3H3 are novel targets for epigenetic silencing in breast cancer
por: Shah, R, et al.
Publicado: (2009)

Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
por: Alam, S M, et al.
Publicado: (2008)

Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer
por: Koussounadis, A, et al.
Publicado: (2014)

DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
por: Lee, S, et al.
Publicado: (2010)

Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer
por: van der Gun, B T F, et al.
Publicado: (2011)

Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium
por: Pearce, C L, et al.
Publicado: (2009)

Methylation status of oestrogen receptor-α gene promoter sequences in human ovarian epithelial cell lines
por: O'Doherty, A M, et al.
Publicado: (2002)

Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2019)

Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas
por: Gubbay, O, et al.
Publicado: (2005)

Gene expression profiling of human ovarian tumours
por: Biade, S, et al.
Publicado: (2006)

No Evidence for FANCF Gene Silencing in Head-and-Neck Squamous Cell Carcinomas
por: Ameziane, Najim, et al.
Publicado: (2009)

The FANCC–FANCE–FANCF complex is evolutionarily conserved and regulates meiotic recombination
por: Singh, Dipesh Kumar, et al.
Publicado: (2023)

A seven-gene prognostic model for platinum-treated ovarian carcinomas
por: Sabatier, R, et al.
Publicado: (2011)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
por: Roberts, D, et al.
Publicado: (2005)

CpG methylation of the FHIT, FANCF, cyclin-D2, BRCA2 and RUNX3 genes in Granulosa cell tumors (GCTs) of ovarian origin
por: Dhillon, Varinderpal S, et al.
Publicado: (2004)

High frequency of complex TP53 mutations in CNS metastases from breast cancer
por: Lo Nigro, C, et al.
Publicado: (2012)

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects
por: Shan, S J C, et al.
Publicado: (2007)

Site-specific CpG methylation in the CCAAT/enhancer binding protein delta (CEBPδ) CpG island in breast cancer is associated with metastatic relapse
por: Palmieri, C, et al.
Publicado: (2012)

The Notch pathway in ovarian carcinomas and adenomas
por: Hopfer, O, et al.
Publicado: (2005)

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer
por: Quaye, L, et al.
Publicado: (2009)

Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis
por: Cunningham, J M, et al.
Publicado: (2009)

Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer
por: Pal, T, et al.
Publicado: (2012)

Sp17 gene expression in myeloma cells is regulated by promoter methylation
por: Wang, Z, et al.
Publicado: (2004)

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
por: Abkevich, V, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_cfls1iih5ml32uad6spv2b4f7k